Navigation Links
Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
Date:3/3/2008

ypertensive drug candidates

-- Euro 0.3 million corresponding to the allocation of the remaining

balance of the US$2 million license and option payments received from

Axcan following the termination of the development of NCX 1000 in May

2007

The initial March 2006 payments from Pfizer and Merck listed above were deferred over the estimated duration of NicOx' involvement in the research and development programs provided for under the terms of the corresponding agreements. The terms surrounding the duration of NicOx' involvements in these programs are revised periodically, if necessary. The payments received from Pfizer for the funding of the research activities are deferred over a period of 12 months from the date of invoice.

Operating expenses

Consolidated operating expenses totaled euro 57.8 million in 2007, compared to euro 36.3 million in 2006, of which, 80.4% were attributable to research and development expenses and 19.6% to selling and administrative expenses during 2007, compared to 78.7% and 21.3%, respectively in 2006.

Research and development expenses reached euro 46.5 million in 2007, compared to euro 28.6 million in 2006 (including euro 2.2 million allocated to cost of sales in 2007 and euro 1.6 million in 2006). These expenses are primarily due to the costs associated with the phase 3 development of naproxcinod, such as expenses related to contract research organizations and suppliers involved in naproxcinod's clinical development and manufacturing activities. At this time, the cost of sales principally corresponds to the expenses incurred by NicOx in performing research activities under the contracts signed with Pfizer and Merck. Operational subsidies from the research tax credit, which are deducted from research and development expenses, amounted to euro 3.9 million in 2007 compared to euro 1.2 million in 2006. On December 31, 2007, the Company employed 84 people in research and development
'/>"/>

SOURCE NicOx S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
3. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
4. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
5. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
6. Progen Pharmaceuticals Announces Fiscal 2007 Financial Results
7. Biopure Announces 2007 Third Quarter Financial Results
8. Xytis Names Gordon H. Busenbark as Chief Financial Officer
9. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
10. Pharmacopeia Announces Third Quarter 2007 Financial Results
11. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014 ... investing £2.5 million to help it meet the ... goods, healthcare, pharmaceuticals and logistics. Albion joins Shackleton ... ) Over the past 18 months ... its platform, its management team and its operations. ...
(Date:7/25/2014)... July 25, 2014  Depomed, Inc. (NASDAQ: ... quarter fiscal year 2014 financial results after the market ... a conference call beginning at 4:30 pm EDT, 1:30 pm PDT ... the call by dialing 877-317-6789 ( United States ... also be available via a live webcast on the ...
(Date:7/25/2014)... 2014 GrowBLOX Sciences, Inc. (OTCQB: GBLX) is pleased ... ("MOU") with LaurelCo, LLC, an Illinois ... cultivation and dispensary medical marijuana licenses in the state of ... will acquire a 20% equity interest in LaurelCo, LLC in ... growing chambers, as well as all technology related to the ...
Breaking Medicine Technology:OmPrompt Funded for Customer Automation Management Market Expansion 2Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 2GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 2GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 3
... and LONDON, Nov. 20 Boston Scientific Corporation (NYSE: ... received 510(k) clearance from the U.S. Food and Drug ... WallFlex® Fully Covered Esophageal Stent for the treatment of ... with resectable or non-resectable esophageal cancer. , (Photo: ...
... , HOUSTON, Nov. 20 Cyberonics, Inc. (Nasdaq: CYBX ... and Greg Browne, Chief Financial Officer, will present at the 21st ... December 2, 2009 at 12:00 PM EST. The conference session ... be presented. Piper Jaffray will host a webcast of the ...
Cached Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2
(Date:7/28/2014)... a healthy lifestyle may help childhood cancer survivors reduce ... indicates. Researchers suggested that children with cancer and ... about how their diet and certain behaviors could ... are important because they indicate that adults who were ... influence their own health outcomes," said one of the ...
(Date:7/28/2014)... 28, 2014 Glidewell Laboratories announced today ... have successfully passed the five-year mark in clinical usage, ... million units prescribed by US dentists. , Even as ... with good results from respected clinical studies, many dentists ... perform over extended years of clinical service before they ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 This ... Global and Chinese Tadalafil industry. The report firstly ... classification, application and manufacturing technology. The report then ... listing their product specification, capacity, Production value, and ... quantitatively 2009-2014 global and China’s total market of ...
(Date:7/28/2014)... Raleigh, NC (PRWEB) July 28, 2014 ... they say is an improved blood test for the ... article on the new research. Click here to ... of Respiratory Medicine at Tokyo’s Juntendo University Graduate School ... biomarker called N-ER/mesothelin is a step above the old ...
(Date:7/28/2014)... July 28, 2014 Community Health Center ... medical, dental, and pharmacy services, has released an article ... chronic disease management . Founded in 1983, the health ... those of the county that face barriers to obtaining ... make an appointment at the CHC, click here: ...
Breaking Medicine News(10 mins):Health News:Healthy Habits May Help Childhood Cancer Survivors Avoid Chronic Ills 2Health News:BruxZir® Solid Zirconia Surpasses Five Years of Clinical Use 2Health News:Global and Chinese Tadalafil Industry 2009-2019 Market Research Report Now Available at LifeScienceIndustryResearch.com 2Health News:Global and Chinese Tadalafil Industry 2009-2019 Market Research Report Now Available at LifeScienceIndustryResearch.com 3Health News:Global and Chinese Tadalafil Industry 2009-2019 Market Research Report Now Available at LifeScienceIndustryResearch.com 4Health News:Test Results Look Promising for New Mesothelioma Blood Test, According to Surviving Mesothelioma 2Health News:Community Health Center of Snohomish Releases Article Focusing on Educating the Chronically Ill About Chronic Disease Management 2Health News:Community Health Center of Snohomish Releases Article Focusing on Educating the Chronically Ill About Chronic Disease Management 3
... Youthful ... Appearance, BEVERLY HILLS, Calif., ... Hills, CA states,"Changing the size and shape of your teeth can significantly ... patients,say that a smile make-over is better than botox in restoring a ...
... Prime Therapeutics (Prime), a,thought leader in pharmacy ... joined the organization as Vice President of,Pharmacy Trade ... Relations, Wan will focus on,developing and maintaining relationships ... in the development of strategic pharmacy,contracts and the ...
... Corporation,(Nasdaq: DRAD ), a leading provider of ... hospitals and imaging centers, today,reported financial results for ... revenues were higher, compared to the same time ... imaging services revenues within Digirad,Imaging Solutions. The Company,s ...
... Group, Inc. (Phyhealth) (Pink Sheets: PHYH), a developer ... announced that Phyhealth Plan Corporation, a wholly-owned subsidiary,of ... to provide,comprehensive vision services for its Pilot HMO ... 2008., Mr. Robert Trinka, chairman and chief ...
... C-Change champions the Cancer Patient Navigation Act on ... sets into motion,a world of confusion and questions ... navigation services brings the patient-focus,back to cancer care ... a,skilled navigator guide him or her thought the ...
... ST. LOUIS, April 23 Young Innovations, Inc.,(Nasdaq: YDNT ... Sales for the first quarter of 2008 were $24.4 ... million reported in the first quarter,of 2007. Income from operations ... from $4.7 million in the first quarter of 2007. Net ...
Cached Medicine News:Health News:'Size Does Matter ... and So Does Shape ... When It Comes to Teeth,' Says Cosmetic Dentist, Dr. Denise Fundora 2Health News:Digirad Corporation Reports Financial Results for First-Quarter 2008 2Health News:Digirad Corporation Reports Financial Results for First-Quarter 2008 3Health News:Digirad Corporation Reports Financial Results for First-Quarter 2008 4Health News:Digirad Corporation Reports Financial Results for First-Quarter 2008 5Health News:Digirad Corporation Reports Financial Results for First-Quarter 2008 6Health News:Digirad Corporation Reports Financial Results for First-Quarter 2008 7Health News:Digirad Corporation Reports Financial Results for First-Quarter 2008 8Health News:Phyhealth Signs Agreement with Advantica EyeCare to Provide Vision Services for Pilot HMO 2Health News:Support for Patient Navigation Services to Help Cancer Patients 2Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008 2Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008 3Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008 4Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008 5
... Implant (KGTI) system offers the latest technology ... MPJ. The implant system is anatomically designed ... ,The KGTI is the most advanced reconstructive ... on the market today. The system consists ...
... Ad-Techs Intraoperative Electrodes share ... electrodes. The main difference is ... discs are numbered to assist ... electrodes are designed for use ...
... the Selenia full field digital mammography ... new era in the world of ... innovation combines the latest advances in ... management capabilities to bring you the ...
... The P3000 heralds a new concept in ... binocular infrared optical system developed for the P2000. ... standard in which we have paid particular attention ... Our new system is extremely flexible, allowing ...
Medicine Products: